Literature DB >> 6809325

Carbohydrate metabolism in cancer cachexia.

C P Holroyde, G A Reichard.   

Abstract

A profound loss of body mass and energy reserves is a characteristic feature of cancer cachexia. Because glucose is a major energy-yielding fuel, abnormalities of carbohydrate metabolism may prove to be important in the development or end-result of this common syndrome. In this paper, we review the known alterations of glucose and lactate metabolism that occur in patients with malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6809325

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  7 in total

1.  Cancer-Associated Anorexia and Cachexia : Implications for Drug Therapy.

Authors:  C L Loprinzi; R M Goldberg; N L Burnham
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 2.  Nutrition in cancer patients.

Authors:  S Mercadante
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

Review 3.  The metabolic environment of cancer.

Authors:  J M Argilés; J Azcón-Bieto
Journal:  Mol Cell Biochem       Date:  1988-05       Impact factor: 3.396

4.  Decreased response to cAMP in the glucose and glycogen catabolism in perfused livers of Walker-256 tumor-bearing rats.

Authors:  Hely de Morais; Priscila Cassola; Carolina Campos Lima Moreira; Suéllen Kathiane Fernandes Vilas Bôas; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Mol Cell Biochem       Date:  2012-05-26       Impact factor: 3.396

5.  Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Horm Cancer       Date:  2013-10-08       Impact factor: 3.869

6.  Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma.

Authors:  R Parimala; P Sachdanandam
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

7.  A study to investigate the incidence of early satiety in patients with advanced cancer.

Authors:  P J Armes; H J Plant; A Allbright; T Silverstone; M L Slevin
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.